The oncofetal H19 RNA connection: Hypoxia, p53 and cancer

被引:206
作者
Matouk, Imad J. [1 ,2 ]
Mezan, Shaul [1 ]
Mizrahi, Aya [1 ]
Ohana, Patricia [1 ]
Abu-lail, Rasha [1 ]
Fellig, Yakov [1 ]
deGroot, Nathan [1 ]
Galun, Eithan [2 ]
Hochberg, Abraham [1 ]
机构
[1] Hebrew Univ Jerusalem, Dept Biol Chem, Alexander Silberman Inst Life Sci, IL-91905 Jerusalem, Israel
[2] Hadassah Hebrew Univ Hosp, Goldyne Savad Inst Gene Therapy, Jerusalem, Israel
来源
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH | 2010年 / 1803卷 / 04期
关键词
Hypoxia; p53 tumor suppressor; H19 non-coding RNA; Hypoxia-inducible factor alpha; Cell viability; INDUCIBLE FACTOR 1-ALPHA; TUMOR-SUPPRESSOR GENE; NONCODING RNA; BLADDER-CARCINOMA; IMPRINTED H19; EXPRESSION; OVEREXPRESSION; PROLIFERATION; TUMORIGENESIS; PRODUCT;
D O I
10.1016/j.bbamcr.2010.01.010
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Expression of the imprinted H19 gene is remarkably elevated in a large number of human cancers. Recently, we reported that H19 RNA is up-regulated in hypoxic stress and furthermore, it possesses oncogenic properties. However, the underlying mechanism(s) of these phenomena remain(s) unknown. Here we demonstrate a tight correlation between H19 RNA elevation by hypoxia and the status of the p53 tumor suppressor. Wild type p53 (p53(wt)) prevents the induction of H19 upon hypoxia, and upon its reconstitution in p53(null) cells. The last case is accompanied by a decrease in cell viability. The p53 effect is nuclear and seems independent of its tetramerization. Furthermore, using knockdown and over-expression approaches we identified HIF1-alpha as a critical factor that is responsible for H19 induction upon hypoxia. Knocking down HIF1-alpha abolishes H19 RNA induction, while its over-expression significantly enhances the H19 elevation in hypoxic cells. In p53(wt) hypoxic cells simultaneous suppression of p53 and over-expression of HIF1-alpha are needed to induce H19 significantly, while each treatment separately resulting in a mild induction, indicating that the molecular mechanism of p53 suppression effect on H19 may at least in part involve interfering with HIF1-alpha activity. In vivo a significant increase in H19 expression occurred in tumors derived from p53(null) cells but not in p53(wt) cells. Taken together, our results indicate that a functional link exists between p53, HIF1-alpha and H19 that determines H19 elevation in hypoxic cancer cells. We suggest that this linkage plays a role in tumor development. (C) 2010 Elsevier B.V. All rights reserved.
引用
收藏
页码:443 / 451
页数:9
相关论文
共 35 条
[1]   THE IMPRINTED H19 GENE AS A TUMOR-MARKER IN BLADDER-CARCINOMA [J].
ARIEL, I ;
LUSTIG, O ;
SCHNEIDER, T ;
PIZOV, G ;
SAPPIR, M ;
DEGROOT, N ;
HOCHBERG, A .
UROLOGY, 1995, 45 (02) :335-338
[2]   Possible physiological role of H19 RNA [J].
Ayesh, S ;
Matouk, I ;
Schneider, T ;
Ohana, P ;
Laster, M ;
Al-Sharef, W ;
de-Groot, N ;
Hochberg, A .
MOLECULAR CARCINOGENESIS, 2002, 35 (02) :63-74
[3]   p53 in the cytoplasm: A question of overkill? [J].
Baptiste, N ;
Prives, C .
CELL, 2004, 116 (04) :487-489
[4]   The c-Myc oncogene directly induces the H19 noncoding RNA by allele-specific binding to potentiate tumorigenesis [J].
Barsyte-Lovejoy, Dalia ;
Lau, Suzanne K. ;
Boutros, Paul C. ;
Khosravi, Fereshteh ;
Jurisica, Igor ;
Andrulis, Irene L. ;
Tsao, Ming S. ;
Penn, Linda Z. .
CANCER RESEARCH, 2006, 66 (10) :5330-5337
[5]   H19 mRNA-like noncoding RNA promotes breast cancer cell proliferation through positive control by E2F1 [J].
Berteaux, N ;
Lottin, V ;
Monté, D ;
Pinte, S ;
Quatannens, B ;
Coll, J ;
Hondermarck, H ;
Curgy, JJ ;
Dugimont, T ;
Adriaenssens, E .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2005, 280 (33) :29625-29636
[6]   p53 inhibits hypoxia-inducible factor-stimulated transcription [J].
Blagosklonny, MV ;
An, WG ;
Romanova, LY ;
Trepel, J ;
Fojo, T ;
Neckers, L .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1998, 273 (20) :11995-11998
[7]   An intact HDM2 RING-finger domain is required for nuclear exclusion of p53 [J].
Boyd, SD ;
Tsai, KY ;
Jacks, T .
NATURE CELL BIOLOGY, 2000, 2 (09) :563-568
[8]   THE PRODUCT OF THE H19 GENE MAY FUNCTION AS AN RNA [J].
BRANNAN, CI ;
DEES, EC ;
INGRAM, RS ;
TILGHMAN, SM .
MOLECULAR AND CELLULAR BIOLOGY, 1990, 10 (01) :28-36
[9]   Epigenetic alterations of H19 and LIT1 distinguish patients with Beckwith-Wiedemann syndrome with cancer and birth defects [J].
DeBaun, MR ;
Niemitz, EL ;
McNeil, DE ;
Brandenburg, SA ;
Lee, MP ;
Feinberg, AP .
AMERICAN JOURNAL OF HUMAN GENETICS, 2002, 70 (03) :604-611
[10]   The H19 TATA-less promoter is efficiently repressed by wild-type tumor suppressor gene product p53 [J].
Dugimont, T ;
Montpellier, C ;
Adriaenssens, E ;
Lottin, S ;
Dumont, L ;
Iotsova, V ;
Lagrou, C ;
Stéhelin, D ;
Coll, J ;
Curgy, JJ .
ONCOGENE, 1998, 16 (18) :2395-2401